Literature DB >> 16037252

Accumulation of advanced glycation end products, measured as skin autofluorescence, in renal disease.

Jasper W L Hartog1, Aiko P J de Vries, Helen L Lutgers, Robbert Meerwaldt, Roel M Huisman, Willem J van Son, Paul E de Jong, Andries J Smit.   

Abstract

Advanced glycation end products (AGEs) accumulate during renal failure and dialysis. Kidney transplantation is thought to reverse this accumulation by restoring renal function. Using a noninvasive and validated autofluorescence reader, we evaluated AGE levels in 285 transplant recipients (mean age, 52 years; range, 41 to 60 years), 32 dialysis patients (mean age, 56 years; range, 43 to 65 years), and 231 normal control subjects (mean age, 51 years; range, 40 to 65 years). Measurements in transplant recipients were performed for a mean of 73 months (range, 32 to 143 months) after transplantation. Dialysis patients were on dialysis therapy for a mean of 42 months (range, 17 to 107 months). Fluorescence was significantly increased in dialysis patients compared with normal control subjects (2.8 vs. 2.0 arbitrary units [a.u.], P < .0001). Although fluorescence levels were significantly decreased in transplant recipients compared with dialysis patients (2.5 vs. 2.8 a.u., P < .0001), fluorescence in transplant recipients was higher than in controls (2.5 vs. 2.0 a.u., P < .0001). In transplant recipients, fluorescence correlated positively with the duration of dialysis prior to transplantation (R = 0.21, P < .0001), and negatively with creatinine clearance (R = -0.34, P < .0001). No correlation was found between time after transplantation and fluorescence in transplant recipients (R = -0.10, P = .10). Fluorescence in dialysis patients was positively correlated with duration of dialysis (R = 0.36, P = .042). Our results, like those of others, suggest that kidney transplantation does not fully correct increased AGE levels found in dialysis patients. The increased AGE levels in kidney transplant recipients cannot be explained by the differences in renal function alone. The availability of a simple, noninvasive method (AGE-Reader) to measure AGE accumulation may be used to monitor AGE accumulation in a clinical setting as well as in a study setting.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16037252     DOI: 10.1196/annals.1333.037

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  22 in total

1.  Partial characterization of the molecular nature of collagen-linked fluorescence: role of diabetes and end-stage renal disease.

Authors:  David R Sell; Ina Nemet; Vincent M Monnier
Journal:  Arch Biochem Biophys       Date:  2009-10-30       Impact factor: 4.013

2.  The influence of body mass index on the accumulation of advanced glycation end products in hemodialysis patients.

Authors:  S Arsov; L Trajceska; W van Oeveren; A J Smit; P Dzekova; B Stegmayr; A Sikole; G Rakhorst; R Graaff
Journal:  Eur J Clin Nutr       Date:  2015-01-14       Impact factor: 4.016

Review 3.  Advanced glycation end products and diabetic retinopathy.

Authors:  Yashodhara Sharma; Sandeep Saxena; Arvind Mishra; Anita Saxena; Shankar Madhav Natu
Journal:  J Ocul Biol Dis Infor       Date:  2013-04-19

4.  Association of plasma levels of soluble receptor for advanced glycation end products and risk of kidney disease: the Atherosclerosis Risk in Communities study.

Authors:  Casey M Rebholz; Brad C Astor; Morgan E Grams; Marc K Halushka; Mariana Lazo; Ron C Hoogeveen; Christie M Ballantyne; Josef Coresh; Elizabeth Selvin
Journal:  Nephrol Dial Transplant       Date:  2014-08-21       Impact factor: 5.992

5.  Below the radar: advanced glycation end products that detour "around the side". Is HbA1c not an accurate enough predictor of long term progression and glycaemic control in diabetes?

Authors:  Josephine M Forbes; Georgia Soldatos; Merlin C Thomas
Journal:  Clin Biochem Rev       Date:  2005-11

Review 6.  Skin Autofluorescence - A Non-invasive Measurement for Assessing Cardiovascular Risk and Risk of Diabetes.

Authors:  Alin Stirban; Lutz Heinemann
Journal:  Eur Endocrinol       Date:  2014-08-28

7.  Tissue-advanced glycation end product concentration in dialysis patients.

Authors:  Natasha J McIntyre; Lindsay J Chesterton; Stephen G John; Helen J Jefferies; James O Burton; Maarten W Taal; Richard J Fluck; Christopher W McIntyre
Journal:  Clin J Am Soc Nephrol       Date:  2009-11-05       Impact factor: 8.237

Review 8.  Peritoneal changes in patients on long-term peritoneal dialysis.

Authors:  Raymond T Krediet; Dirk G Struijk
Journal:  Nat Rev Nephrol       Date:  2013-05-14       Impact factor: 28.314

9.  Skin autofluorescence is elevated in acute myocardial infarction and is associated with the one-year incidence of major adverse cardiac events.

Authors:  D J Mulder; P L van Haelst; R Graaff; R O Gans; F Zijlstra; A J Smit
Journal:  Neth Heart J       Date:  2009-04       Impact factor: 2.380

Review 10.  Advanced glycation end products: role in pathology of diabetic cardiomyopathy.

Authors:  Vijaya Lakshmi Bodiga; Sasidhar Reddy Eda; Sreedhar Bodiga
Journal:  Heart Fail Rev       Date:  2014-01       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.